Comment
. 2004 Nov;10(11):1154-5; author reply 1155.
doi: 10.1038/nm1104-1154.
Translation of cancer immunotherapies
- PMID: 15516901
- DOI: 10.1038/nm1104-1154
Item in Clipboard
Comment
Translation of cancer immunotherapies
Nat Med.
2004 Nov.
No abstract available
Comment on
-
Cancer immunotherapy: breaking the barriers to harvest the crop.Nat Med. 2004 Sep;10(9):887-92. doi: 10.1038/nm0904-887. Nat Med. 2004. PMID: 15340404
Similar articles
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. doi: 10.1038/nm1104-1153a. Nat Med. 2004. PMID: 15516900 No abstract available.
-
Can single-patient investigational new drug studies hurry slow trains to the fast track?Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4. Drug Discov Today. 2006. PMID: 16580594
-
Update on the National Cancer Institute's clinical trials cooperative group program.J Am Coll Radiol. 2004 Nov;1(11):865-6. doi: 10.1016/j.jacr.2004.07.009. J Am Coll Radiol. 2004. PMID: 17411719 Review. No abstract available.
-
New office and new leader aim to streamline FDA cancer drug review process.J Natl Cancer Inst. 2005 May 18;97(10):708-9. doi: 10.1093/jnci/97.10.708. J Natl Cancer Inst. 2005. PMID: 15900036 No abstract available.
-
New opportunities for the development of cancer immunotherapies.Cancer J Sci Am. 1998 May;4 Suppl 1:S1-4. Cancer J Sci Am. 1998. PMID: 9619263 Review. No abstract available.
Cited by
-
Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
